It is hypothesized that Fgf2 and Fgfr1 are downregulated in depression and anxiety, and this downregulation can be partially reversed by antidepressant treatment (Turner, Watson & Akil, 2012b; Turner, Watson & Akil, 2012a). This evidence concerns the gene FGFR1 and depressive symptom measurement.